FDA Adverse Event Injury Summary report: N

INGEVITY+

MDR report key: 20123444 · Received September 3, 2024

Report

Report Number
2124215-2024-54810
Event Type
Injury
Date Received
September 3, 2024
Date of Event
August 5, 2024
Report Date
September 25, 2024
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
NVN
UDI-DI
00802526604522
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Description of Event or Problem · 0

IT WAS REPORTED THAT THIS RIGHT VENTRICULAR (RV) LEAD HAD PACING FAILURE AFTER IMPLANTATION AND ALSO EXHIBITED HIGH PACING THRESHOLDS. IN ADDITION, THE PHYSICIAN BELIEVES THAT IT WAS DUE TO DISLODGEMENT. THIS LEAD WAS SURGICALLY REVISE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Description of Event or Problem · 0

IT WAS REPORTED THAT THIS RIGHT VENTRICULAR (RV) LEAD HAD PACING FAILURE AFTER IMPLANTATION AND ALSO EXHIBITED HIGH PACING THRESHOLDS. IN ADDITION, THE PHYSICIAN BELIEVES THAT IT WAS DUE TO DISLODGEMENT. THIS LEAD WAS SURGICALLY REVISE AND REMAINS IN SERVICE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
899505 INGEVITY+ IMPLANTABLE LEAD NVN BOSTON SCIENTIFIC CORPORATION 7842 1298756 00802526604522

Patients

Seq Age Sex Outcome Treatment
1 61 YR Male Required Intervention| H